
In a large study, a national team of researchers led by Mayo Clinic scientists observed that self-reported use of hormone therapy was associated with a significantly lower colorectal cancer risk. However, the mechanisms for the apparent protective association are still unclear. The study, being presented at the annual meeting of the American Association for Cancer Research, was designed to look at possible links between estrogen exposure and colon cancer molecular subtypes, to determine how these hormones might function as anti-cancer agents. David Limsui, M.D., a fellow in the Department of Gastroenterology at Mayo Clinic, is the study's lead author.
Shortly before Thanksgiving 2021, Jerry Haines, a part-time farmer and retired butter and cheesemaker, was helping another farmer with fall chores. He felt good but ...
May is Bladder Cancer Awareness Month, which makes this a good time to learn about the risk factors for bladder cancer and what you can do ...
May is Brain Cancer Awareness Month, which makes this a good time to learn about metastatic brain cancer. Overall, the chance that a person will develop ...